Bright Minds Biosciences Inc.

Healthcare · Biotechnology · United States

Last price 54.98 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 544.36M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neurop...